Dr. Meeks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- University of Virginia Medical CenterResidency, Pediatrics, 2001 - 2004
- University of Mississippi School of MedicineClass of 2001
Certifications & Licensure
- GA State Medical License 2004 - 2025
- VA State Medical License 2001 - 2004
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.Amy Dunn, Yesim Dargaud, Yasmina Abajas, Manuel Carcao, Giancarlo Castaman
Haemophilia. 2024-12-15 - Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production.Elizabeth S York, Benjamin D Dratch, Jasmine Ito, Samantha M Horwitz, Sahand Emamian
Journal of Thrombosis and Haemostasis. 2024-10-28 - Marginal Zone B Cells Represent a Conserved Initiating Player in the Immune Response to Factor VIII in Hemophilia A Mice.Maya Maarouf, Seema R Patel, Wallace Hunter Baldwin, Patricia E Zerra, Courtney Cox
Thrombosis and Haemostasis. 2024-09-01
Abstracts/Posters
- Severe Bleeding Events in Hemophilia _ Patients Receiving Emicizumab ProphylaxisShannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia aShannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study FindsSeptember 9th, 2019
- Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A PatientsAugust 29th, 2019
Grant Support
- Mechanisms Of Immunogenicity Of Factor VIIINational Heart, Lung, And Blood Institute2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: